Pegasus Partners Ltd. increased its stake in Centene Corporation (NYSE:CNC) by 39.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,257 shares of the company’s stock after buying an additional 4,870 shares during the period. Pegasus Partners Ltd.’s holdings in Centene were worth $1,741,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Elk Creek Partners LLC boosted its holdings in Centene by 11.5% in the third quarter. Elk Creek Partners LLC now owns 5,264 shares of the company’s stock worth $509,000 after purchasing an additional 542 shares during the period. Mutual of America Capital Management LLC boosted its holdings in Centene by 1.6% in the third quarter. Mutual of America Capital Management LLC now owns 34,834 shares of the company’s stock worth $3,371,000 after purchasing an additional 562 shares during the period. Savant Capital LLC boosted its holdings in Centene by 19.7% in the third quarter. Savant Capital LLC now owns 3,580 shares of the company’s stock worth $346,000 after purchasing an additional 590 shares during the period. CIBC Asset Management Inc boosted its holdings in Centene by 4.0% in the third quarter. CIBC Asset Management Inc now owns 16,475 shares of the company’s stock worth $1,594,000 after purchasing an additional 630 shares during the period. Finally, Eqis Capital Management Inc. boosted its holdings in Centene by 5.1% in the fourth quarter. Eqis Capital Management Inc. now owns 13,862 shares of the company’s stock worth $1,398,000 after purchasing an additional 672 shares during the period. 92.03% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have commented on CNC. Leerink Swann reaffirmed a “market perform” rating and issued a $90.00 price objective (down previously from $100.00) on shares of Centene in a report on Tuesday. Credit Suisse Group boosted their price target on shares of Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a report on Wednesday, February 7th. Cantor Fitzgerald boosted their price target on shares of Centene from $115.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Morgan Stanley boosted their price target on shares of Centene from $118.00 to $126.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Finally, Citigroup reissued an “outperform” rating and set a $130.00 price target (up previously from $122.00) on shares of Centene in a report on Wednesday, February 7th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $110.28.

In related news, EVP Jesse N. Hunter sold 10,000 shares of the company’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $98.73, for a total value of $987,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert K. Ditmore sold 8,750 shares of the company’s stock in a transaction dated Monday, January 8th. The stock was sold at an average price of $104.30, for a total transaction of $912,625.00. The disclosure for this sale can be found here. Insiders sold 32,500 shares of company stock valued at $3,311,613 in the last ninety days. Corporate insiders own 3.00% of the company’s stock.

Shares of Centene Corporation (NYSE CNC) opened at $103.00 on Wednesday. The firm has a market cap of $17,879.62, a PE ratio of 21.96, a P/E/G ratio of 0.97 and a beta of 0.71. Centene Corporation has a 1-year low of $65.03 and a 1-year high of $112.42. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.93 and a quick ratio of 0.99.

Centene (NYSE:CNC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.03. The business had revenue of $12.81 billion during the quarter, compared to the consensus estimate of $12.25 billion. Centene had a net margin of 1.71% and a return on equity of 13.68%. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.19 earnings per share. analysts forecast that Centene Corporation will post 7.23 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/centene-corporation-cnc-shares-bought-by-pegasus-partners-ltd/1865560.html.

Centene Company Profile

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.